ProfCeline Marmion

Professor

Department of Chemistry

  • Professor
    Department of Chemistry
  • 353 1 4022161 (Work)
  • RCSI, Chemistry, 123 St Stephens Green, Dublin 2

RESEARCH OVERVIEW

Cancer is one of the most complex and deadly diseases known to man. Although today nearly 50% of all anti-cancer therapies are Pt-based, surprisingly to date only three Pt drugs have been approved for worldwide clinical use, namely cisplatin, carboplatin and oxaliplatin. The cytotoxicity of Pt drugs is attributed to their ability to bind DNA and induce apoptosis. There are drawbacks however associated with their use (such as their limited activity against many common human cancers, their susceptibility to acquired drug resistance and their toxicity) which limits their widespread application and efficacy. The search for metallodrugs (Pt or non-Pt based) which (i) target the cell and/or (ii) have a different mode of action to Pt drugs currently in clinical use remains the subject of intense investigation. We are currently exploring a number of different strategies with a view to developing metallodrugs with enhanced selectivity for the cell nucleus and, in so doing, advance a new class of chemotherapeutic beyond those currently in use.

GRANTS

  • FUNDED PROJECT
    StEP Programme 2026-27
    RCSI1 Oct 2026 - 30 Sep 2027
  • FUNDED PROJECT
    Student Selected Projects (SSP) 2026
    RCSI9 Feb 2026 - 21 Dec 2026
  • FUNDED PROJECT
    StEP Programme 2025-26
    RCSI30 Sep 2025 - 29 Sep 2027
  • FUNDED PROJECT
    Cross-Cultural Perspectives on Student Engagement and Partnership and If and How they Influence Student Belonging in a Health Professions Education Context: A Comparative Analysis Amongst Undergraduate Students in a Western versus Asian Context
    Irish Network of Healthcare Educators INHED18 Aug 2025 - 31 Jul 2026
  • FUNDED PROJECT
    StEP Programme
    RCSI30 Sep 2024 - 29 Sep 2027
  • FUNDED PROJECT
    Student Selected Projects (SSP) 2024
    RCSI29 Apr 2024 - 28 Apr 2025
  • FUNDED PROJECT
    Collaborative Initiative 2023/24
    RCSI1 Sep 2023 - 28 Feb 2025
  • FUNDED PROJECT
    Embedding a universal culture of student partnership across RCSI - a study to identify key enablers from a staff and student perspective
    Irish Network of Medical Educators - INMED7 Feb 2022 - 6 Feb 2023
  • FUNDED PROJECT
    Student Engagement and Partnership (StEP) Projects
    RCSI1 Jan 2021 - 31 Dec 2021
  • FUNDED PROJECT
    Student Engagement and Partnership (StEP) Projects
    Industry1 Jan 2021 - 31 Dec 2025
  • FUNDED PROJECT
    Platinum(IV) Prodrugs for Precision Cancer Therapy
    Enterprise Ireland H2020 Support11 Oct 2019 - 10 Jul 2020
  • FUNDED PROJECT
    SSC Research Programme 2019
    RCSI1 Jan 2019 - 31 Dec 2021
  • FUNDED PROJECT
    Innovative Metallodrugs as Potent Anti-Cancer Therapeutics
    Enterprise Ireland H2020 Support11 Oct 2018 - 15 Jan 2019
  • FUNDED PROJECT
    StAR International PhD Programme
    RCSI1 Oct 2018 - 31 Dec 2025
  • FUNDED PROJECT
    Metallodrug Design and Action
    RCSI1 Sep 2018 - 31 Aug 2027
  • FUNDED PROJECT
    Breaking the cancer drug resistance paradigm: a novel prodrug strategy for multi-modal chemotherapeutics
    Science Foundation Ireland (SFI)1 Jan 2018 - 31 Dec 2018
    People funded by this grant:
    • Andrew K
  • FUNDED PROJECT
    Innovative Metallodrugs as Potent Anti-Cancer Therapeutics (IMPACT)
    RCSI8 May 2017 - 7 May 2018
  • FUNDED PROJECT
    Introducing the concept of palliative care – an analysis of student perceptions of the influence and utility of a first year elective
    Irish Network of Medical Educators - INMED11 Mar 2017 - 10 Mar 2018
    People funded by this grant:
    • Laura RF
  • FUNDED PROJECT
    Innovative Metallodrugs as Potent Anti-Cancer Therapeutics (TBC)
    Enterprise Ireland H2020 Support2 Nov 2016 - 23 Jul 2017
  • FUNDED PROJECT
    Multi-Functional Metallodrug Candidates as Anti-Cancer Agents
    Industry16 Jun 2016 - 15 Dec 2017
  • FUNDED PROJECT
    Novel Metallodrug Candidates for Therapeutic Exploitation
    Private Donor1 Apr 2014 - 1 Apr 2019
  • FUNDED PROJECT
    An In Vivo Study of Novel Multi-Functional Metallodrug Candidates as Anti-Cancer Agents: A Crucial Step in their Commercialisation
    Science Foundation Ireland (SFI)1 Jan 2013 - 31 Dec 2014
  • FUNDED PROJECT
    Exploiting Chromatin as a New Molecular Target for the Development of Novel Metallochemotherapeutics with Enhanced Selectivity and Activity Towards Cancer Cells
    Science Foundation Ireland (SFI)1 Sep 2011 - 31 Aug 2016
    People funded by this grant:
    • Viktor B
  • FUNDED PROJECT
    Metallo-Drug Design and Action (Phase 2)
    European Cooperation in Science & Technology (COST)1 Feb 2011 - 18 Jul 2011
  • FUNDED PROJECT
    Metallo-Drug Design and Action (Phase 1)
    European Cooperation in Science & Technology (COST)1 Feb 2010 - 31 Jan 2011